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HYPERTROPHIC CARDIOMYOPATHY
Impaired Response of Left Ventricular Relaxation to Exercise-Induced
Adrenergic Stimulation in Patients With Hypertrophic Cardiomyopathy
HIDEO IZAWA, MD, MITSUHIRO YOKOTA, MD, PHD, FACC, KOHZO NAGATA, MD, PHD,
MITSUNORI IWASE, MD, PHD, TOSHIKAZU SOBUE, MD, PHD
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Objectives. We investigated the effect of adrenergic stimulation
on left ventricular relaxation in patients with hypertrophic car-
diomyopathy.
Background. Exercise-induced decreases in acceleration of left
ventricular relaxation have been observed in patients with hyper-
trophic cardiomyopathy. However, data on sequential changes in
left ventricular relaxation during exercise are limited.
Methods. We measured right (ﬂuid ﬁlled) and left (high ﬁdelity
micromanometer) ventricular pressures during moderate supine
ergometer exercise and during rapid right atrial pacing in four
groups of patients: 9 with severe hypertrophic cardiomyopathy, 9
with moderate hypertrophic cardiomyopathy, 10 with hyperten-
sion and moderate hypertrophy and 5 control subjects.
Results. There was a curvilinear relation between the time
constant of relaxation (tau) and heart rate in all groups during
exercise. There was no difference in the slope of this relation
between the two hypertrophic cardiomyopathy subgroups. Al-
though the slope of this relation between tau and heart rate was
steeper in the hypertensive than the moderate hypertrophic
cardiomyopathy group (p < 0.001, analysis of covariance), the
decrease in tau during right atrial pacing was similar in both
groups. There were no signiﬁcant differences in plasma levels of
catecholamines at rest or at peak exercise among groups or in
maximal heart rate during pacing.
Conclusions. Pacing-induced changes in tau in hypertrophic
cardiomyopathy were similar to those in hypertensive hypertro-
phy, but remarkable decreases in exercise-induced acceleration of
tau were observed only in hypertrophic cardiomyopathy. Our
results may indicate a depressed left ventricular relaxation re-
sponse to exercise-induced adrenergic stimulation in hypertrophic
cardiomyopathy.
(J Am Coll Cardiol 1996;28:1738–45)
1996 by the American College of Cardiology
Although exercise induces marked acceleration of left ventric-
ular relaxation in normal subjects, patients with hypertrophic
cardiomyopathy exhibit decreased acceleration of left ventric-
ular relaxation in response to exercise (1). However, little is
known about sequential changes in left ventricular relaxation
during exercise in patients with left ventricular hypertrophy.
In the present study, we examined sequential changes in left
ventricular relaxation during exercise and investigated whether
the depressed acceleration of left ventricular relaxation in
response to exercise in patients with hypertrophic cardiomy-
opathy is due to a depressed response to exercise-induced
adrenergic stimulation. Increases in heart rate itself lead to
increased contractility (the Bowditch effect) and a shortening
of relaxation (2,3). Therefore, we examined left ventricular
relaxation during rapid right atrial pacing to assess the effect of
the heart rate itself on the relation between heart rate and left
ventricular relaxation during exercise. Because left ventricular
relaxation is related to the severity of hypertrophy (4), we
studied subgroups of patients with severe and moderate hyper-
trophy to investigate the effect of hypertrophy on changes in
the time constant of relaxation (tau) during exercise. We also
studied patients with essential hypertension who had left
ventricular hypertrophy similar in degree to that in patients in
the moderate hypertrophic cardiomyopathy group and in
control patients without left ventricular hypertrophy or hyper-
tension.
Methods
Study patients (Table 1). We evaluated 18 patients with
nonobstructive hypertrophic cardiomyopathy (17 men, 1 wom-
an; mean age 53 years, range 37 to 72). The diagnosis of
nonobstructive hypertrophic cardiomyopathy was based on
echocardiographic demonstration of a nondilated, hypertro-
phied left ventricle without evidence of left ventricular outﬂow
tract obstruction in the absence of other cardiac or systemic
disease that could produce left ventricular hypertrophy (5).
The diagnosis was conﬁrmed by cardiac catheterization and
angiography. No patients with apical hypertrophy, as indicated
by a spade-shaped conﬁguration on left ventriculography, were
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included in the study. Patients were classiﬁed as having severe
or moderate hypertrophic cardiomyopathy according to
whether their echocardiographically determined left ventricu-
lar mass index was 200 or 200 g/m2, respectively. We also
studied 10 patients with left ventricular hypertrophy due to
essential hypertension who had a mean left ventricular mass
index 200 g/m2 (hypertensive group) to investigate the
possibility that the pathogenesis of left ventricular hypertrophy
is the major determinant of the relation between heart rate and
left ventricular relaxation during dynamic exercise. No patient
in the hypertrophic cardiomyopathy or hypertensive groups
had any associated cardiac diseases, including atrioventricular
conduction abnormalities, right or left bundle branch block or
other coronary or pulmonary diseases. The control group
included ﬁve patients who underwent cardiac catheterization
for evaluation of atypical chest pain and in whom no coronary
disease was present. No patient in the control group had a past
history of hypertension, and no evidence of left ventricular
hypertrophy was detected on electrocardiograms (ECGs), ven-
triculograms or echocardiograms. No study subject had signif-
icant coronary artery stenosis 50% reduction in lumen
diameter on coronary arteriography.
All drugs were discontinued at least 4 days before the study.
The study was approved by the appropriate institutional review
committee. Patients were informed in detail of the purpose
and method of the study and provided written informed
consent.
Measurement of left ventricular mass. Two-dimensional
echocardiographic studies were performed with a Hewlett-
Packard 77030A ultrasonoscope, and images were recorded on
0.5 in. VHS videotape recorders. Images were obtained in the
parasternal long- and short-axis views and apical two- and
four-chamber views. Echocardiographic analysis was per-
formed by two observers (K.N., M.I.) who were unaware of the
patient’s clinical status. Echocardiographic left ventricular
mass was calculated by the area–length method as recom-
mended by the American Society of Echocardiography (6).
The left ventricular mass index was calculated by dividing left
ventricular mass by body surface area (m2).
Because hypertrophy may be asymmetric and localized in
patients with hypertrophic cardiomyopathy, echocardiographic
measurement of left ventricular mass may not truly reﬂect the
extent of hypertrophy. Thus, in addition to determining echo-
cardiographic left ventricular mass, the degree of asymmetric
hypertrophy was semiquantitated with a point score (7), with a
maximum of 10 points: 1 to 4 points for septal hypertrophy on
the basis of magnitude of thickness; up to 4 points for the
length of asymmetric hypertrophy from the parasternal and
apical views; and 2 points for anterolateral extension of
hypertrophy seen on the short-axis view.
Cardiac catheterization. Patients received premedication
with 5 mg of oral diazepam before catheterization. A 6F pigtail
angiographic high ﬁdelity micromanometer-tipped catheter
(model SPC-464D, Millar Instruments) was advanced into the
left ventricle through the right brachial artery for measurement
of left ventricular pressure. The micromanometer pressure was
matched to the pressure of the ﬂuid-ﬁlled lumen. A 20-g
catheter was placed in the left brachial artery for arterial pres-
sure measurements. A 6F bipolar pacing catheter was intro-
duced through the left brachial vein and positioned in the right
atrium. A 7F triple-lumen thermistor Swan-Ganz catheter
(Baxter Healthcare Co.) was positioned in the pulmonary
artery through the right brachial vein to measure pulmonary
artery wedge pressure and cardiac output. A pulmonary artery
wedge pressure transducer (model 746, Siemens Medical Sys-
Abbreviations and Acronyms
ANCOVA  analysis of covariance
ANOVA  analysis of variance
dP/dt  ﬁrst derivative of left ventricular pressure
ECG  electrocardiogram
tau  time constant of relaxation
TD  tau determined by the derivative method
T1/2  tau determined by the pressure half-time method













Male/female 8/1 9/0 10/0 5/0
Age (yr) 53  10 55  5 56  7 51  8
LVMI (g/m2) 256  39 160  17* 156  15* 103  13*†‡
LVEF (%) 74.0  3.9 72.0  2.8 69.5  4.3 63.6  2.1*†
LVESVI (ml/m2) 15.4  2.6 15.7  2.0 17.8  7.3 25.8  1.1*†§
LVEDVI (ml/m2) 59.2  3.3 56.2  4.3 58.7  8.0 70.6  5.7*†§
*p  0.01 versus severe hypertrophic cardiomyopathy (HCM) group. †p  0.01 versus moderate hypertrophic
cardiomyopathy group. ‡p  0.01 versus hypertensive hypertrophy (HT) group. §p  0.05 versus hypertensive
hypertrophy group. Data presented are mean value  SD or number of patients. LVEF  left ventricular ejection
fraction; LVEDVI  left ventricular end-diastolic volume index; LVESVI  left ventricular end-systolic volume index;
LVMI  left ventricular mass index.
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tems, Inc., Solna, Sweden) was placed at the zero reference
point midchest level.
After bicycle ergometer exercise tests were completed,
selective coronary angiography and left ventriculography were
performed in all subjects.
Rapid right atrial pacing tests. After all catheters were in
place, right atrial pacing was initiated at 80 beats/min and
increased by 10-beat/min increments to a maximum of 110
beats/min to assess the effect of the heart rate on left ventric-
ular relaxation in the moderate hypertrophic cardiomyopathy
and hypertensive groups. Modiﬁed 12-lead ECGs, left ventric-
ular pressure and the ﬁrst derivative of left ventricular pressure
(dP/dt) were recorded every 3 min at each heart rate. No
patient had right or left bundle branch block during right atrial
pacing. Complete data could not be obtained in two patients
because of the presence of variations in baseline heart rates
and Mobitz I second-degree heart block at rapid rates. No
study patient had right or left bundle branch block during right
atrial pacing.
Bicycle ergometer exercise tests. Patients performed low
grade bicycle ergometer exercise tests in the supine position
according to a previously described method (8). Patients in the
moderate hypertrophic cardiomyopathy and hypertensive
groups performed ergometer exercise tests 30 min after the
pacing protocol was completed. The work load was initiated at
25 W for 3 min and then increased to 50 W. The test was
stopped after patients had exercised for 6 min. Modiﬁed
12-lead ECGs and hemodynamic measurements were obtained
at rest and every 3 min during exercise. Micromanometer
pressure signals and a bipolar standard ECG lead were re-
corded continuously on a nine-channel cassette frequency
modulation recorder (MR-40, TEAC Co.). During exercise, no
patient had a change in the outﬂow tract gradient, as assessed
by Doppler echocardiography, and none had right or left
bundle branch block on the modiﬁed 12-lead ECGs.
Determination of plasma catecholamine concentrations. A
7-ml volume of blood was collected from the brachial artery at
rest, at maximal heart rate during pacing and at peak exercise.
Blood samples were centrifuged at 5,000 rpm at 4C for 10 min.
Plasma samples (3 ml) were stored at70C until assayed. The
plasma level of norepinephrine was analyzed by radioenzy-
matic assay using a commercial kit.
Data analysis. Left ventricular pressure signals were digi-
tized at 3-ms intervals and analyzed with a 16-bit microcom-
puter system (PC-9801VX, NEC Co., Tokyo, Japan). Left
ventricular pressure data at rest and during the last 2 min of
each 3-min stage of the exercise protocol were selected for
analysis. To compensate for changes in the intrathoracic
pressure during breathing, steady state measurements were
averaged over a 12-s recording period that spanned multiple
respiratory cycles. Extrasystolic and postextrasystolic beats
were excluded from analysis.
To investigate left ventricular isovolumetric relaxation, tau
was calculated in two ways: 1) A modiﬁcation of the method
described by Raff and Glantz (9) in which tau (TD) is deter-
mined from the inverse negative slope of the relation between
left ventricular pressure and dP/dt. Pressure data from the
point at the peak negative dP/dt to a pressure equal to
5 mm Hg above the previous left ventricular end-diastolic
pressure were used for this calculation. 2) Direct measurement
of the pressure half-time (T1/2), as described by Mirsky (10). A
time constant T1/2 was computed for each acquisition as the
time required for the pressure at the time of peak negative
dP/dt to decline to one-half of its value at peak negative dP/dt.
Because of the afterload dependency of tau, the index of tau
divided by left ventricular peak systolic pressure was calculated
(11).
Left ventricular end-systolic and end-diastolic volumes were
determined by biplane ventriculography and calculated by the
area–length method (12).
Statistical analysis. Results are expressed as mean value
SD. One-way factorial analysis of variance (ANOVA) was
used to compare baseline characteristics and hemodynamic
variables at each exercise stage among four groups and hemo-
dynamic variables at rest and at maximal heart rate during
pacing between two groups. Within-group comparisons were
performed for the hemodynamic changes during exercise and
pacing with two-way repeated measures ANOVA. When a
signiﬁcant difference was present, intergroup comparisons
were made with Scheffe´’s multiple comparison test. The rela-
tion between tau and heart rate at rest and during each
exercise stage was assessed by the nonlinear least-squares
ﬁtting technique, as appropriate. Between-group comparisons
of the regression lines or curves were determined by analysis of
covariance (ANCOVA), with individual differences analyzed
by Scheffe´’s multiple comparison test. A p value 0.05 was
considered statistically signiﬁcant.
Results
No complications were associated with the exercise test or
pacing protocol. No patient reported severe dyspnea or chest
pain during the exercise test or pacing protocol. Left ventric-
ular hypertrophy score was signiﬁcantly higher in the severe
than the moderate hypertrophic cardiomyopathy group (7.3 
1.0 vs. 5.7  0.8 points, respectively, p  0.01).
Hemodynamic variables during supine ergometer exercise
tests. Rest and exercise hemodynamic variables are summa-
rized in Table 2. There were exercise-induced increases in
pulmonary artery wedge pressures and left ventricular end-
diastolic pressures in all groups, but there were no signiﬁcant
differences in these variables among the four groups during
exercise. There were no signiﬁcant differences among groups
in cardiac index or peak positive dP/dt at rest or in response to
exercise. Tau (both TD and T1/2) at rest was signiﬁcantly
prolonged in the severe hypertrophic cardiomyopathy group
compared with that in the other groups, was similar to that in
the moderate hypertrophic cardiomyopathy and hypertensive
groups and tended to be lower than that in the control group
than in these two groups. TD at 50 W of exercise was
signiﬁcantly prolonged in the moderate hypertrophic cardio-
myopathy group compared with that in the hypertensive and
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control groups. A further prolongation occurred in the severe
hypertrophic cardiomyopathy group. T1/2 at 50 W of exercise
showed a similar pattern. The index of TD divided by left
ventricular peak systolic pressure at 50 W of exercise was
signiﬁcantly higher in the moderate hypertrophic cardiomyop-
athy group than the hypertensive and control groups and was
even higher in the severe hypertrophic cardiomyopathy group.
The index of T1/2 divided by left ventricular peak systolic
pressure at 50 W of exercise showed a similar pattern.
Heart rate and TD were signiﬁcantly correlated during







(LVMI 200 g/m2) Control
HR (beats/min)
Rest 64  13 65  12 69  13 65  6
25 W 89 12 93  12 89  12 87  8
50 W 103 14 109  12 101  12 98  8
CI (liters/min per m2)
Rest 3.0  1.0 2.7  0.5 2.8  0.7 2.6  0.4
25 W 4.2 0.7 4.6  0.8 4.3  0.7 4.4  0.5
50 W 5.4 0.7 5.1  0.5 5.0  0.7 4.9  0.5
PAWP (mm Hg)
Rest 8  3 6  2 6  2 8  2
25 W 18 5 14  3 14  5 12  3
50 W 20 12 16  4 16  5 14  3
LVEDP (mm Hg)
Rest 12  6 8  3 8  4 10  2
25 W 20 9 15  8 16  8 14  3
50 W 24 10 17  5 18  7 14  3
LVPSP (mm Hg)
Rest 130  15‡ 127  10‡ 157  10* 122  9
25 W 145 16‡ 137  10‡ 178  11* 132  9
50 W 154 16‡ 149  11‡ 195  9* 140  11
Peak dP/dt (mm Hg/s)
Rest 1,445  129 1,592  345 1,749  362 1,597  516
25 W 1,797 203 2,248  578 2,357  511 1,930  472
50 W 2,132 365 2,718  790 2,950  582 2,697  773
Peak dP/dt (mm Hg/s)
Rest 1,248  212‡ 1,587  391 2,008  272 1,756  338
25 W 1,545 261‡ 2,117  506 2,597  403 2,170  262
50 W 1,764 405‡ 2,288  602 2,934  484 2,811  1130
TD (ms)
Rest 87  16*‡ 66  7 58  9 48  5
25 W 72 12*‡ 52  4 42  9 39  8
50 W 66 13*‡ 48  4†§ 35  5 33  6
T1/2 (ms)
Rest 61  9*‡¶ 50  5* 44  7 36  1
25 W 55 8*‡¶ 44  4* 34  6 27  2
50 W 52 8*‡ 41  2*‡ 31  5 23  2
TD/LVPSP (ms/mm Hg)
Rest 0.65  0.11*‡¶ 0.52  0.08§ 0.37  0.07 0.40  0.04
25 W 0.48 0.07*‡¶ 0.38  0.05‡ 0.23  0.05 0.30  0.08
50 W 0.41 0.07*‡¶ 0.32  0.05‡ 0.18  0.02 0.24  0.07
T1/2/LVPSP (ms/mm Hg)
Rest 0.46  0.07*‡ 0.40  0.04*‡ 0.28  0.04 0.30  0.02
25 W 0.37 0.06*‡ 0.32  0.02*‡ 0.20  0.04 0.21  0.03
50 W 0.32 0.05*‡ 0.28  0.03*‡ 0.16  0.03 0.16  0.01
*p  0.01, †p  0.05 versus control group. ‡p  0.01, §p  0.05 versus hypertensive hypertrophy group. p  0.01,
¶p  0.05 versus moderate hypertrophic cardiomyopathy group. Data presented are mean value  SD. CI  cardiac
index; dP/dt  ﬁrst derivative of left ventricular pressure; HR  heart rate; LVEDP  left ventricular end-diastolic
pressure; LVPSP  left ventricular peak systolic pressure; PAWP  pulmonary artery wedge pressure; TD and T1/2 
tau calculated by derivative method and direct pressure half-time method, respectively; positive; negative; other
abbreviations as in Table 1.
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exercise in all groups (Fig. 1). The slope of the curve was
signiﬁcantly less steep in the severe (p  0.001, ANCOVA)
and moderate hypertrophic cardiomyopathy groups (p 
0.001, ANCOVA) than that in the hypertensive group. The
severe and moderate hypertrophic cardiomyopathy groups
showed parallel upward shifts in the curve of the relation
between heart rate and TD. There was little overlap in the plots
of the same heart rates among the severe and moderate
hypertrophic cardiomyopathy and hypertensive groups. The
slope of the curve was similar in the hypertensive and control
groups.
The relation between heart rate and T1/2 was similar to that
between heart rate and TD, that is, the slope of the relation was
less steep in the hypertrophic cardiomyopathy groups than that
in the hypertensive and control groups (Fig. 2).
Heart rate and the index of TD divided by left ventricular
peak systolic pressure were signiﬁcantly correlated during
exercise in all groups (severe hypertrophic cardiomyopathy
group: r  0.54, p  0.01; moderate hypertrophic cardiomy-
opathy group: r  0.88, p  0.001; hypertensive group: r 
0.88, p  0.001; control group: r  0.86, p  0.001), and
the slope of the relation was less steep in the hypertrophic
cardiomyopathy groups than that in the hypertensive and
control groups. The relation between heart rate and the index
of T1/2 divided by left ventricular peak systolic pressure was
similar to that between heart rate and the index of TD divided
by left ventricular peak systolic pressure.
Effect of right atrial pacing tachycardia on left ventricular
relaxation. The effect of exercise on left ventricular relaxation
was blunted in patients with moderate hypertrophic cardiomy-
opathy versus those with hypertension (Fig. 3). Tachycardia
produced a signiﬁcant decrease in tau in both groups (Table 3).
Although the decrease in tau was greater at an exercise work
load of 50 W in the moderate hypertrophic cardiomyopathy
group than in the hypertensive group (p  0.01), there was no
signiﬁcant difference in tau between the two groups at maximal
heart rate during pacing.
Changes in plasma levels of catecholamines. Exercise in-
duced increases in the plasma levels of norepinephrine in all
groups; however, there were no signiﬁcant differences among
groups in plasma levels of norepinephrine at rest (severe
hypertrophic cardiomyopathy group: 220  19 pg/ml; moder-
ate hypertrophic cardiomyopathy group: 255  54 pg/ml;
hypertensive group: 223  40 pg/ml; control group: 211  48
pg/ml) or during peak exercise (severe hypertrophic cardiomy-
opathy group: 470  54 pg/ml; moderate hypertrophic cardio-
myopathy group: 508  208 pg/ml; hypertensive group: 613 
184 pg/ml; control group: 458  75 pg/ml). Plasma levels of
epinephrine were also similar in all four groups. There was no
signiﬁcant difference in plasma levels of norepinephrine be-
tween the moderate hypertrophic cardiomyopathy group and
the hypertensive group at maximal heart rate during pacing
(248  21 vs. 242  42 pg/ml, respectively). Plasma levels of
norepinephrine at maximal heart rate during pacing were not
signiﬁcantly different from rest values.
Discussion
Our study clearly demonstrated that the effect of exercise
on left ventricular relaxation was blunted in patients with
hypertrophic cardiomyopathy versus those with hypertensive
Figure 1. Scatterplot showing relation between heart rate and TD at
rest and during exercise. 1  severe hypertrophic cardiomyopathy
(solid circles [r  0.47, p  0.01]); 2  moderate hypertrophic
cardiomyopathy (open circles [r  0.90, p  0.001]); 3  hyperten-
sive hypertrophy (triangles [r  0.93, p  0.001]); 4  control group
(crossmarks [r  0.82, p  0.01]). bpm  beats per minute.
Figure 2. Scatterplot showing relation between heart rate and T1/2 at
rest and during exercise. 1 severe hypertrophic cardiomyopathy (r
0.49, p  0.01); 2  moderate hypertrophic cardiomyopathy (r 
0.71, p  0.001); 3  hypertensive hypertrophy (r  0.87, p 
0.001); 4  control group (r  0.86, p  0.01). bpm  beats per
minute. Symbols as in Figure 1.
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hypertrophy. We observed a curvilinear relation between heart
rate and tau. The slope of the curve representing this relation
was less steep in patients with hypertrophic cardiomyopathy
than in those with hypertension, and the degree of left
ventricular hypertrophy did not inﬂuence the slope of the
curve. The decrease in tau during right atrial pacing at
equivalent heart rates was similar in patients with hypertrophic
cardiomyopathy and in hypertensive patients who had a similar
degree of left ventricular hypertrophy, indicating that there
was no difference in the effect of tachycardia on tau between
these groups. The plasma levels of catecholamines did not
differ among groups at rest, at peak exercise or at maximal
heart rate during pacing. These results support the hypothesis
that the pathogenesis of hypertrophy (hypertrophic cardiomyo-
pathic vs. hypertensive etiology) inﬂuences sequential changes
in tau related to exercise-induced adrenergic stimulation.
Effects of afterload on relaxation. One cannot ignore the
effect of afterload on tau (13), especially during exercise where
left ventricular peak systolic pressure is increasing. The index
of tau divided by left ventricular peak systolic pressure (11) was
calculated in the present study. Heart rate and this index were
signiﬁcantly correlated during exercise in all groups, and the
slope of the relation was less steep in the hypertrophic
cardiomyopathy groups than the hypertensive and control
groups. These ﬁndings were in accordance with those between
heart rate and tau; however, they should be interpreted with
great care, because the afterload dependence of tau cannot be
corrected simply by using division by left ventricular peak
systolic pressure, and the effect of afterload on the sequential
changes in tau during exercise in hypertrophic cardiomyopathy
may be complex. Reduced inactivation, as is the case in
hypertrophic cardiomyopathy (14), would reduce the load
dependence of relaxation (15), and the effect of severe hyper-
trophy in hypertrophic cardiomyopathy would reduce afterload
for a given peak systolic pressure (7).
Comparison with a previous study. To our knowledge, this
is the ﬁrst study to demonstrate a diminished relaxation
response in patients with hypertrophic cardiomyopathy during
exercise versus atrial pacing. In a previous study, Udelson et al.
(15) demonstrated that beta-adrenergic stimulation with iso-
proterenol enhances left ventricular relaxation in hypertrophic
cardiomyopathy compared with the effects of pacing tachycar-
dia at the same heart rate. In their study, isoproterenol
reduced T1/2, increased peak negative dP/dt and decreased
minimal diastolic pressure. Several potential reasons could
explain the discrepancy between our and their data: 1) During
isoproterenol infusion, Udelson et al. observed unchanged left
ventricular end-diastolic pressure; however, in the present
study, we observed increased left ventricular end-diastolic
pressure in patients with hypertrophic cardiomyopathy during
exercise, which may reﬂect severe ischemia induced by exer-
cise. 2) Udelson et al. (15) studied patients with hypertrophic
cardiomyopathy with left ventricular outﬂow tract obstruction,
whereas we studied patients with nonobstructive hypertrophic
cardiomyopathy. Moreover, there may be differences in the
severity of hypertrophy between our patients with hypertrophic
cardiomyopathy and theirs. Unfortunately, they did not mea-
sure left ventricular mass in their study patients.
Underlying mechanisms of depressed acceleration of relax-
ation. A number of factors may be responsible for the de-
pressed acceleration of left ventricular relaxation response to
exercise-induced adrenergic stimulation in hypertrophic car-
diomyopathy compared with hypertensive hypertrophy, includ-
ing impaired calcium transient, increased nonuniformity in
space and time and aggravated regional ischemia.
Impaired calcium transient. Exercise induces an increase in
catecholamine levels. Beta-adrenergic stimulation enhances
left ventricular relaxation in association with increases in the
Figure 3. Relation between heart rate and TD during right atrial
pacing (solid circles) and exercise (open circles) in a representative
patient in the moderate hypertrophic cardiomyopathy group (top) and
one in the hypertensive hypertrophy group (bottom). Pacing-induced
sequential changes in tau were the same in both patients, but exercise-
induced sequential changes in tau differed remarkably between the two.
Note that the effect of exercise on relaxation was blunted in the patient
with hypertrophic cardiomyopathy compared with that in the patient with
hypertensive hypertrophy. bpm  beats per minute.
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rate of calcium uptake from the myocellular cytosol into the
sarcoplasmic reticulum induced by phosphorylation of phos-
pholamban (16). No abnormalities in the number of beta-
adrenoreceptors or adenylate cyclase activity of the ventricular
septum or the right atrium have been observed in patients with
hypertrophic cardiomyopathy who have undergone operation
(17). In a recent study (18), the intracellular adenylate cyclase
pathway was found to be normal in the WKY/NCrj rat model
for hypertrophic cardiomyopathy. These previous studies show
evidence of intact beta-adrenoreceptor systems in hypertrophic
cardiomyopathy, and, indeed, in the present study there was no
signiﬁcant difference in the response of heart rate to the
beta-adrenergic stimulation induced by exercise between pa-
tients with hypertrophic cardiomyopathy and control subjects.
There were no differences in plasma levels of catecholamines
between the hypertrophic cardiomyopathy and hypertensive
groups at rest or at peak exercise. Nevertheless, the accelera-
tion of left ventricular relaxation during exercise was depressed
in patients with hypertrophic cardiomyopathy versus those with
hypertensive hypertrophy. We speculate that one of the mech-
anisms of this depressed left ventricular relaxation response to
exercise may be a smaller Ca2 uptake reserve of the sarco-
plasmic reticulum, which responds to exercise-induced adren-
ergic stimulation in patients with hypertrophic cardiomyopathy
versus those with hypertensive hypertrophy. Thus, the rate of
sarcoplasmic reticulum Ca2 uptake may reach a plateau
earlier in patients with hypertrophic cardiomyopathy than in
hypertensive patients. In other words, exercise-induced adren-
ergic stimulation exceeds the depressed ability of Ca2 uptake
by the sarcoplasmic reticulum in patients with hypertrophic
cardiomyopathy and exacerbates Ca2 overload (14). In iso-
lated muscle of patients with hypertrophic cardiomyopathy, the
effects of forskolin (an agent that increases intracellular cyclic
adenosine monophosphate directly), which attenuated an in-
crease in end-diastolic tension, thus reﬂecting end-diastolic
cytosolic Ca2 uptake, are less at higher frequencies of stim-
ulation than at lower frequencies (14), in support of this
hypothesis. Direct studies of the sarcoplasmic reticulum (19)
have shown that the capacity of sarcoplasmic reticulum Ca2
uptake is not unlimited in the isolated canine ventricular
myocardium, providing partial support for this hypothesis. In
the present study, there was a nonlinear relation between heart
rate and tau, not only in patients with hypertrophic cardiomy-
opathy and hypertensive hypertrophy but also in control
subjects, suggesting that the limited lusitropic capacity may
have been related to sarcoplasmic reticulum Ca2 uptake
capacity. Further pathophysiologic studies are needed to con-
ﬁrm these possibilities.
Nonuniformity and regional ischemia. Diastolic asynchrony
is a common ﬁnding in patients with hypertrophic cardiomy-
opathy and hypertensive hypertrophy (20,21). The cause of
nonuniformity in hypertrophic cardiomyopathy is unclear but
might be due to regional differences in load, metabolic condi-
tions and wall stiffness (21). Nonuniformity might result from
ischemia (22), which has been characterized as the presence of
increased wall stress and coronary vascular resistance and
small-vessel disease, especially in the hypertrophied septum in
hypertrophic cardiomyopathy (7). Impaired relaxation of the
myocardium during the isovolumetric and rapid ﬁlling periods
could impair coronary ﬁlling and also result in ischemia (7). In
contrast, myocardial ischemia could act to impair relaxation by
a number of mechanisms (23). Indeed, it is known that
impaired left ventricular relaxation is closely related to asyn-
chrony in ischemic and normal myocardium during coronary
occlusion (22). In the clinical setting, regional myocardial
ischemia has been revealed in hypertrophic cardiomyopathy by
means of abnormal thallium perfusion (24,25). Accordingly,
exercise-induced adrenergic stimulation may aggravate re-
gional ischemia in patients with hypertrophic cardiomyopathy,
resulting in increased regional nonuniformity and, therefore, a
blunted response of left ventricular relaxation. To our knowl-
edge, no previous study has discriminated between hypertro-
phic cardiomyopathy and hypertensive hypertrophy in terms of
regional nonuniformity at rest or during exercise. Differences
in nonuniformity during exercise between hypertrophic cardio-
myopathy and hypertensive hypertrophy may play an impor-
tant role in the depressed left ventricular relaxation response
to exercise in hypertrophic cardiomyopathy compared with
hypertensive hypertrophy. Further studies are needed to clarify
this issue.
Study limitations. This study has several limitations: 1)
The most important limitation is the use of two-dimensional
echocardiography for quantitative assessment of left ventricu-
lar mass in patients with hypertrophic cardiomyopathy. Two-
dimensional echocardiography using the area–length method
is an accurate technique for determination of left ventricular
mass in patients with hypertensive hypertrophy (6); however,
in patients with hypertrophic cardiomyopathy, in whom hyper-
trophy may be asymmetric and localized, the accuracy of this
technique as an estimate of degree of hypertrophy is likely to
be diminished. Therefore, the degree of asymmetric hypertro-
phy was semiquantitated with a point score developed by Wigle
et al. (7) in the present study. This point score method has
been validated against measurements of left ventricular mass
by magnetic resonance imaging (26).
Table 3. Effects of Right Atrial Pacing and Exercise on Tau
Pacing Exercise
Rest Max Rest 50 W
Moderate HCM
HR (beats/min) 65  9 108  3* 66  12 109  11*
TD (ms) 65  6 52  4* 66  7 48  4*
T1/2 (ms) 49  6 41  4* 50  5 41  2*
HT
HR (beats/min) 68  10 110  0* 67  15 101  11*
TD (ms) 61  7 50  3† 60  9 35  5*§
T1/2 (ms) 45  6 38  4† 44  7 31  5*‡
*p  0.01, †p  0.05 versus rest. ‡p  0.01, §p  0.05 versus moderate
hypertrophic cardiomyopathy group. Max  maximal heart rate (HR) during
right atrial pacing; Rest  at rest before exercise or before right atrial pacing;
other abbreviations as in Tables 1 and 2.
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2) The use of a simple exponential model to characterize
the time course of the fall in left ventricular pressure provides
only an approximation. The assumption of a monoexponential
pressure decline for calculation of tau may not be appropriate
in ventricles in which there is signiﬁcant asynchrony of con-
traction and relaxation, as is the case in hypertrophic cardio-
myopathy (15). Thus, we also applied T1/2 as a time constant of
isovolumetric relaxation, which is an index of a nonexponential
curve-ﬁtting model according to the method of Mirsky (10).
The results of TD as well as T1/2 were concordant in the present
study.
3) Elastic recoil, which is determined by left ventricular
end-systolic volume, is an important determinant of relaxation
rate (11). Regrettably, we did not measure left ventricular
end-systolic volume during exercise, and our data did not
clarify the role of elastic recoil in relaxation during exercise.
Conclusions. Our study clearly demonstrated that the
exercise-induced acceleration of left ventricular relaxation was
blunted in patients with hypertrophic cardiomyopathy com-
pared with patients with hypertensive hypertrophy. There was
a curvilinear relation between heart rate and tau during
exercise in hypertrophied hearts. Pacing-induced changes in
tau in hypertrophic cardiomyopathy were similar to those in
hypertensive hypertrophy, but exercise-induced changes in tau
differed remarkably. It is therefore tempting to speculate that
sequential changes in tau during exercise may be related to the
pathogenesis of left ventricular hypertrophy (hypertrophic
cardiomyopathic vs. hypertensive etiology). Our ﬁndings sug-
gest that differences in sequential changes in tau between
patients with hypertrophic cardiomyopathy and hypertensive
patients are related to the left ventricular relaxation response
to exercise-induced adrenergic stimulation.
We thank Stephen F. Vatner, MD for helpful review of the manuscript. We also
thank Takashi Miyahara, MD, Hitoshi Ishihara, MD, Masahiko Ukai, MD,
Ryozo Kato, MD, Hirofumi Kanda, MD, Takeshi Machii, MD, Yasuto Nishi-
naka, MD and Takaharu Fujimura, MD for their cooperation. We thank Sadako
Ichihashi for assistance in preparation of the manuscript.
References
1. Murgo JP, Craig WE, Pasipoularides A. Evaluation of time course of left
ventricular isovolumic relaxation in humans. In: Grossman W, Lorell BH,
editors. Diastolic Relaxation of the Heart. Boston: Nijhoff Publishing;
1988:125–32.
2. Freeman GL, Little WC, O’Rourke RA. Inﬂuence of heart rate on the left
ventricular performance in conscious dog. Circ Res 1987;61:455–64.
3. Karliner JS, LeWinter MM, Mahler F, Engler R, O’Rourke RA. Pharma-
cological and hemodynamic inﬂuences on the rate of isovolumetric left
ventricular relaxation in the normal conscious dog. J Clin Invest 1976;60:
511–21.
4. Haber HL, Powers ER, Gimple LW, et al. Intracoronary angiotensin-
converting enzyme inhibition improves diastolic function in patients with
hypertensive left ventricular hypertrophy. Circulation 1994;89:2616–25.
5. Maron BJ, Epstein SE. Hypertrophic cardiomyopathy: a discussion of
nomenclature. Am J Cardiol 1979;43:1242–4.
6. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantita-
tion of the left ventricle by two-dimensional echocardiography. J Am Soc
Echocardiogr 1989;2:358–67.
7. Wigle ED, Sasson Z, Henderson MA, et al. Hypertrophic cardiomyopathy:
the importance of the site and the extent of hypertrophy: a review. Prog
Cardiovasc Dis 1985;28:1–83.
8. Yokota M, Miyahara T, Iwase M, et al. Hemodynamic mechanisms of
antianginal action of calcium channel blocker nisoldipine in dynamic
exercise-induced angina. Circulation 1990;81:1887–98.
9. Raff GL, Glantz SA. Volume loading slows left ventricular isovolumic
relaxation rate: evidence of load-dependent relaxation in the intact dog
heart. Circ Res 1981;48:813–24.
10. Mirsky I. Assessment of diastolic function: suggested methods and future
considerations. Circulation 1984;69:836–41.
11. Eichhorn EJ, Willard JE, Alvarez L, Glamann DB, Risser RC, Grayburn PA.
Are contraction and relaxation coupled in patients with and without
congestive heart failure? Circulation 1992;85:2132–9.
12. Dodge HT, Sandler H, Baxley WA, Hawley RR. Usefulness and limitations
of radiographic methods for determining left ventricular volume. Am J
Cardiol 1966;18:10–24.
13. Brutsaert DL, Rademakers FE. Triple control of relaxation: implications in
cardiac disease. Circulation 1983;69:190–6.
14. Gwathmey JK, Warren SE, Briggs GM, et al. Diastolic dysfunction in
hypertrophic cardiomyopathy. J Clin Invest 1991;87:1023–31.
15. Udelson JE, Cannon RO III, Bacharach SL, Rumble TF, Bonow RO.
-Adrenergic stimulation with isoproterenol enhances left ventricular dia-
stolic performance in hypertrophic cardiomyopathy despite potentiation of
myocardial ischemia: comparison to rapid atrial pacing. Circulation 1989;79:
371–82.
16. Sasaki T, Inui M, Kuzuya T, Tada M. Molecular mechanism of regulation of
Ca2 pump ATPase by phospholamban in cardiac sarcoplasmic reticulum.
J Biol Chem 1992;267:1674–9.
17. Wagner JA, Sax FL, Weisman HF, et al. Calcium-antagonist receptors in the
atrial tissue of patients with hypertrophic cardiomyopathy. N Engl J Med
1989;320:755–61.
18. Yamamoto S, Katsume H, Nakagawa M, Kuribayashi T, Hashimoto T,
Kuriyama K. The -adrenergic receptor/adenylate cyclase system in the
cardiac ventricles of a hypertrophic cardiomyopathy rat model. Jpn Circ J
1992;56:376–83.
19. Feher JJ, Briggs FN. The effect of calcium load on the calcium permeability
of sarcoplasmic reticulum. J Biol Chem 1982;257:10191–9.
20. Palmon LC, Reichek N, Yeon SB, et al. Intramural myocardial shortening in
hypertensive left ventricular hypertrophy with normal pump function. Cir-
culation 1994;89:122–31.
21. Betocchi S, Hess OM, Losi MA, Nonogi H, Krayenbuehl HP. Regional left
ventricular mechanics in hypertrophic cardiomyopathy. Circulation 1993;
88(Pt 1):2206–14.
22. Kumada T, Karliner J, Pouleur H, Gallagher KP, Shirato K, Ross J Jr.
Effects of acute coronary occlusion on early ventricular events in conscious
dogs. Am J Physiol 1979;237:H542–9.
23. Wigle ED, Rakowski H, Kimball BP, Williams WG. Hypertrophic cardio-
myopathy: clinical spectrum and treatment. Circulation 1995;92:1680–92.
24. Cannon RO, Dilsizian V, O’Gara PT, et al. Impact of operative relief of
outﬂow obstruction on thallium perfusion abnormalities in hypertrophic
cardiomyopathy. Circulation 1992;85:1039–45.
25. Takata J, Counihan PJ, Gane JN, et al. Regional thallium-201 washout and
myocardial hypertrophy in hypertrophic cardiomyopathy and its relation to
exertional chest pain. Am J Cardiol 1993;72:211–8.
26. Rakowski H, Sasson Z, Wigle ED. Echocardiographic and doppler assess-
ment of hypertrophic cardiomyopathy. J Am Soc Echocardiogr 1988;1:31–
47.
1745JACC Vol. 28, No. 7 IZAWA ET AL.
December 1996:1738–45 SEQUENTIAL CHANGES IN TAU DURING EXERCISE
